Annelies E. Lucas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Annelies E. Lucas has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Bart P. Thoonen
Department of General Practice, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500, HB, Nijmegen, the Netherlands
1 shared publication - Chris van Weel
Department of Primary and Community Care, Radboud University medical center, Nijmegen, the Netherlands
1 shared publication Frank J. Smeenk
1 shared publication- Ivo J Smeele
COPD and Asthma General Practitioner Advisory Group (CAHAG), P.O. Box 3231, 3502 GE Utrecht, the Netherlands
1 shared publication Ivo J. Smeele
1 shared publication- Joke G Grootens-Stekelenburg
Department of Primary and Community Care, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands
1 shared publication
Latest Publications
- 1 August 2012
- Published by Elsevier in Respiratory Medicine
- Vol. 106 (8) , 1158-1163
Diagnostic accuracy of primary care asthma/COPD working hypotheses, a real life study
- 1 August 2012
- Published by Elsevier in Respiratory Medicine
- Vol. 106 (8) , 1158-1163
Diagnostic accuracy of primary care asthma/COPD working hypotheses, a real life study
- Open Access
- 22 March 2012
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 12 (1) , 12
Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects
Background: Current COPD guidelines advocate a fixed < 0.70 FEV1/FVC cutpoint to define airflow obstruction. We compared rate of lung function decline in respiratory symptomatic 40+ subjects who were 'obstructive' or 'non-obstructive' according to the fixed and/or age and gender specific lower limit of normal (LLN) FEV1/FVC cutpoints. Methods: We studied 3,324 respiratory symptomatic subjects referred to primary care diagnostic centres for spirometry. The cohort was subdivided into four categories based on presence or absence of obstruction according to the fixed and LLN FEV1/FVC cutpoints. Postbronchodilator FEV1 decline served as primary outcome to compare subjects between the respective categories. Results: 918 subjects were obstructive according to the fixed FEV1/FVC cutpoint; 389 (42%) of them were non-obstructive according to the LLN cutpoint. In smokers, postbronchodilator FEV1 decline was 21 (SE 3) ml/year in those non-obstructive according to both cutpoints, 21 (7) ml/year in those obstructive according to the fixed but not according to the LLN cutpoint, and 50 (5) ml/year in those obstructive according to both cutpoints (p = 0.004). Conclusion: This study showed that respiratory symptomatic 40+ smokers and non-smokers who show FEV1/FVC values below the fixed 0.70 cutpoint but above their age/gender specific LLN value did not show accelerated FEV1 decline, in contrast with those showing FEV1/FVC values below their LLN cutpoint.
- 22 March 2012
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 12 (1) , 12
Open AccessLung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects
Background: Current COPD guidelines advocate a fixed < 0.70 FEV1/FVC cutpoint to define airflow obstruction. We compared rate of lung function decline in respiratory symptomatic 40+ subjects who were 'obstructive' or 'non-obstructive' according to the fixed and/or age and gender specific lower limit of normal (LLN) FEV1/FVC cutpoints. Methods: We studied 3,324 respiratory symptomatic subjects referred to primary care diagnostic centres for spirometry. The cohort was subdivided into four categories based on presence or absence of obstruction according to the fixed and LLN FEV1/FVC cutpoints. Postbronchodilator FEV1 decline served as primary outcome to compare subjects between the respective categories. Results: 918 subjects were obstructive according to the fixed FEV1/FVC cutpoint; 389 (42%) of them were non-obstructive according to the LLN cutpoint. In smokers, postbronchodilator FEV1 decline was 21 (SE 3) ml/year in those non-obstructive according to both cutpoints, 21 (7) ml/year in those obstructive according to the fixed but not according to the LLN cutpoint, and 50 (5) ml/year in those obstructive according to both cutpoints (p = 0.004). Conclusion: This study showed that respiratory symptomatic 40+ smokers and non-smokers who show FEV1/FVC values below the fixed 0.70 cutpoint but above their age/gender specific LLN value did not show accelerated FEV1 decline, in contrast with those showing FEV1/FVC values below their LLN cutpoint.